Clinical trials
Completed Liposarcoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 7 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 9 |
| Dana-Farber Cancer Institute | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Alliance for Clinical Trials in Oncology | 2 |
| Boehringer Ingelheim | 2 |
| Children's Oncology Group | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2 |
| OHSU Knight Cancer Institute | 2 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2 |
| Valerio Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liposarcoma | 48 |
| Sarcoma | 39 |
| Leiomyosarcoma | 28 |
| Histiocytoma, Malignant Fibrous | 22 |
| Fibrosarcoma | 21 |
| Sarcoma, Synovial | 18 |
| Hemangiosarcoma | 17 |
| Neurofibrosarcoma | 14 |
| Dermatofibrosarcoma | 10 |
| Osteosarcoma | 10 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.